Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 15 de 15
Filter
1.
Am J Public Health ; 113(12): 1322-1331, 2023 12.
Article in English | MEDLINE | ID: mdl-37939328

ABSTRACT

Objectives. To examine whether workplace interventions to increase workplace flexibility and supervisor support and decrease work-family conflict can reduce cardiometabolic risk. Methods. We randomly assigned employees from information technology (n = 555) and long-term care (n = 973) industries in the United States to the Work, Family and Health Network intervention or usual practice (we collected the data 2009-2013). We calculated a validated cardiometabolic risk score (CRS) based on resting blood pressure, HbA1c (glycated hemoglobin), HDL (high-density lipoprotein) and total cholesterol, height and weight (body mass index), and tobacco consumption. We compared changes in baseline CRS to 12-month follow-up. Results. There was no significant main effect on CRS associated with the intervention in either industry. However, significant interaction effects revealed that the intervention improved CRS at the 12-month follow-up among intervention participants in both industries with a higher baseline CRS. Age also moderated intervention effects: older employees had significantly larger reductions in CRS at 12 months than did younger employees. Conclusions. The intervention benefited employee health by reducing CRS equivalent to 5 to 10 years of age-related changes for those with a higher baseline CRS and for older employees. Trial Registration. ClinicalTrials.gov Identifier: NCT02050204. (Am J Public Health. 2023;113(12):1322-1331. https://doi.org/10.2105/AJPH.2023.307413).


Subject(s)
Cardiovascular Diseases , Workplace , Humans , Infant , Risk Factors , Long-Term Care , Cardiovascular Diseases/epidemiology , Cardiovascular Diseases/prevention & control
2.
Front Behav Neurosci ; 12: 188, 2018.
Article in English | MEDLINE | ID: mdl-30214402

ABSTRACT

In developing youth, allergic asthma is the most common chronic condition, with 9%-10% of youth affected. Asthma onset during childhood and adolescence is further associated with other health issues, particularly psychiatric conditions. To understand causal mechanisms by which developmental asthma may lead to altered behavior, brain and health trajectories, we developed a mouse model of developmental allergic asthma. In the current study, we tested for potential long-term effects of developmental asthma on adult lung function and behavior and brain gene expression associated with emotion and stress regulation. We manipulated airway inflammation (AI) and methacholine (MCH)-induced bronchospasm (resulting in labored breathing, LB) in young male and female BALB/cJ mice and measured adult outcomes 3 months after final asthma manipulations. Results indicated that allergen exposure, used to cause AI, and which ended on post-natal day 56 (P56), led to persistent lung AI, mucus buildup and gene expression related to allergic asthma 3 months after final allergen exposure. In addition, at this same age, early allergen exposure led to altered brain gene expression related to stress regulation (prefrontal corticotropin releasing hormone receptor 1, Crhr1 and hippocampal glucocorticoid receptor, GR) and serotonin function (brainstem serotonin transporter, SERT). On the other hand, LB events during development led to altered anxiety-related behavior. Importantly, sex and pre-asthma fear-related behavior (ultrasonic vocalization, USV rates) modulated these adult outcomes. Asthma that develops during childhood/adolescence may have long-term impacts on emotion and stress regulation mechanisms, and these influences may be moderated by sex and pre-asthma temperament.

3.
PLoS One ; 13(6): e0198935, 2018.
Article in English | MEDLINE | ID: mdl-29912970

ABSTRACT

Nicotine and alcohol are often co-abused. Adolescence is a vulnerable period for the initiation of both nicotine and alcohol use, which can lead to subsequent neurodevelopmental and behavioral alterations. It is possible that during this vulnerable period, use of one drug leads to neurobiological alterations that affect subsequent consumption of the other drug. The aim of the present study was to determine the effect of nicotine exposure during adolescence on ethanol intake, and the effect of these substances on brain gene expression. Forty-three adolescent female C57BL/6J mice were assigned to four groups. In the first phase of the experiment, adolescent mice (PND 36-41 days) were exposed to three bottles filled with water or nicotine (200 µg/ml) for 22 h a day and a single bottle of water 2 h a day for six days. In the second phase (PND 42-45 days), the 4-day Drinking-in-the-Dark paradigm consisting of access to 20% v/v ethanol or water for 2h or 4h (the last day) was overlaid during the time when the mice did not have nicotine available. Ethanol consumption (g/kg) and blood ethanol concentrations (BEC, mg %) were measured on the final day and whole brains including the cerebellum, were dissected for RNA sequencing. Differentially expressed genes (DEG) were detected with CuffDiff and gene networks were built using WGCNA. Prior nicotine exposure increased ethanol consumption and resulting BEC. Significant DEG and biological pathways found in the group exposed to both nicotine and ethanol included genes important in stress-related neuropeptide signaling, hypothalamic-pituitary-adrenal (HPA) axis activity, glutamate release, GABA signaling, and dopamine release. These results replicate our earlier findings that nicotine exposure during adolescence increases ethanol consumption and extends this work by examining gene expression differences which could mediate these behavioral effects.


Subject(s)
Brain/drug effects , Ethanol/adverse effects , Gene Expression/drug effects , Nicotine/adverse effects , Age Factors , Animals , Brain/metabolism , Drug Synergism , Ethanol/blood , Female , Mice, Inbred C57BL , Neuropeptides/metabolism , Neurotransmitter Agents/metabolism , Signal Transduction/drug effects
4.
Behav Brain Res ; 326: 244-255, 2017 05 30.
Article in English | MEDLINE | ID: mdl-28284954

ABSTRACT

Human and animal studies have shown that physical challenges and stressors during adolescence can have significant influences on behavioral and neurobiological development associated with internalizing disorders such as anxiety and depression. Given the prevalence of asthma during adolescence and increased rates of internalizing disorders in humans with asthma, we used a mouse model to test if and which symptoms of adolescent allergic asthma (airway inflammation or labored breathing) cause adult anxiety- and depression-related behavior and brain function. To mimic symptoms of allergic asthma in young BALB/cJ mice (postnatal days [P] 7-57; N=98), we induced lung inflammation with repeated intranasal administration of house dust mite extract (most common aeroallergen for humans) and bronchoconstriction with aerosolized methacholine (non-selective muscarinic receptor agonist). Three experimental groups, in addition to a control group, included: (1) "Airway inflammation only", allergen exposure 3 times/week, (2) "Labored breathing only", methacholine exposure once/week, and (3) "Airway inflammation+Labored breathing", allergen and methacholine exposure. Compared to controls, mice that experienced methacholine-induced labored breathing during adolescence displayed a ∼20% decrease in time on open arms of the elevated plus maze in early adulthood (P60), a ∼30% decrease in brainstem serotonin transporter (SERT) mRNA expression and a ∼50% increase in hippocampal serotonin receptor 1a (5Htr1a) and corticotropin releasing hormone receptor 1 (Crhr1) expression in adulthood (P75). This is the first evidence that experimentally-induced clinical symptoms of adolescent asthma alter adult anxiety-related behavior and brain function several weeks after completion of asthma manipulations.


Subject(s)
Anxiety/etiology , Asthma , Behavior, Animal , Gene Expression , Hippocampus/metabolism , Muscarinic Agonists/pharmacology , Pyroglyphidae/immunology , Age Factors , Animals , Asthma/chemically induced , Asthma/complications , Asthma/immunology , Asthma/physiopathology , Disease Models, Animal , Female , Male , Methacholine Chloride/pharmacology , Mice , Mice, Inbred BALB C , Sex Factors
5.
Health Psychol ; 36(2): 160-168, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27786517

ABSTRACT

OBJECTIVE: The study examined diurnal regulation of salivary alpha-amylase (sAA) in association with daily stressors, adult day services (ADS) use, and other caregiving characteristics. METHOD: A sample of 165 family caregivers of individuals with dementia (IWD) completed an 8-day diary study. Caregivers provided 5 saliva samples across the 8 days. On some days, caregivers provided all or most of the care. On other days, their relative attended ADS for part of the day. A 3-level unconditional linear spline model was fit to describe the typical sAA diurnal rhythms. Predictors were then added to the unconditional model to test the hypotheses on ADS use and daily stressors. RESULTS: Daily ADS use did not have an effect on diurnal sAA regulation. However, controlling for daily ADS use, greater ADS use over the 8 days was associated with a more prominent rise between 30 min after wake-up and before lunch, and a more prominent decline between before lunch and late afternoon. Fewer ADS days were associated with a more flattened sAA diurnal rhythm. Additionally, greater daily care-related stressor exposures had a within-person association with lower sAA levels in the late afternoon. Care-related stressor exposures had significant within- and between-person associations with sAA diurnal slopes. Furthermore, daily positive experiences had a significant between-person association with sAA diurnal slopes. CONCLUSIONS: Caring for a disabled family member may heighten the vulnerability to potential physiological conditions. Respite from care stressors from ADS use may have some biobehavioral benefits on sAA regulations. (PsycINFO Database Record


Subject(s)
Caregivers/psychology , Circadian Rhythm/physiology , Dementia/nursing , Salivary alpha-Amylases/analysis , Stress, Psychological/physiopathology , Adult , Aged , Aged, 80 and over , Female , Humans , Interpersonal Relations , Male , Middle Aged , Saliva/chemistry , Stress, Psychological/psychology
6.
J Epidemiol Community Health ; 70(12): 1155-1161, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27225680

ABSTRACT

BACKGROUND: Observational studies have linked work-family issues with cigarette consumption. This study examined the 6-month effects on cigarette consumption of a work-family supportive organisational intervention among nursing home workers. METHODS: Group randomised controlled trial where 30 nursing homes across New England states were randomly assigned to either usual practice or to a 4-month intervention aimed at reducing work-family conflict via increased schedule control and family supportive supervisory behaviours (FSSB). Cigarette consumption was based on self-reported number of cigarettes per week, measured at the individual level. RESULTS: A total of 1524 direct-care workers were enrolled in the trial. Cigarette consumption was prevalent in 30% of the sample, consuming an average of 77 cigarettes/week. Smokers at intervention sites reduced cigarette consumption by 7.12 cigarettes, while no reduction was observed among smokers at usual practice sites (b=-7.12, 95% CI -13.83 to -0.40, p<0.05) (d=-0.15). The majority of smokers were US-born White nursing assistants, and among this subgroup, the reduction in cigarette consumption was stronger (b=-12.77, 95% CI -22.31 to -3.22, p<0.05) (d=-0.27). Although the intervention prevented a decline in FSSB (d=0.08), effects on cigarette consumption were not mediated by FSSB. CONCLUSIONS: Cigarette consumption was reduced among smokers at organisations where a work-family supportive intervention was implemented. This effect, however, was not explained by specific targets of the intervention, but other psychosocial pathways related to the work-family interface. TRIAL REGISTRATION NUMBER: NCT02050204; results.

7.
Gerontologist ; 54(4): 570-9, 2014 Aug.
Article in English | MEDLINE | ID: mdl-23690056

ABSTRACT

PURPOSE: We examine the effects of use of adult day service (ADS) by caregivers of individuals with dementia (IWD) on daily stressors, affect, and health symptoms. Participants were interviewed for 8 consecutive days. On some days, the IWD attended an ADS program and on the other days caregivers provide most or all of the care at home. METHODS: Participants were 173 family caregivers of IWDs using an ADS program. Daily telephone interviews assessed care-related stressors, noncare stressors, positive events, affect, and health symptoms. Multilevel models with data nested within persons were used to examine effects of ADS use on daily stressor exposure, affect, and health symptoms. RESULTS: Caregivers had lower exposure to care-related stressors on ADS days, more positive experiences, and more noncare stressors. ADS use lowered anger and reduced the impact of noncare stressors on depressive symptoms. IMPLICATIONS: The findings demonstrate that stressors on caregivers are partly lowered, and affect is improved on ADS days, which may provide protection against the effects of chronic stress associated with caregiving.


Subject(s)
Activities of Daily Living/psychology , Adaptation, Psychological , Caregivers/psychology , Day Care, Medical , Dementia/psychology , Stress, Psychological/psychology , Work/psychology , Adult , Aged , Aged, 80 and over , Dementia/therapy , Female , Humans , Male , Middle Aged , Stress, Psychological/etiology
8.
Curr Drug Abuse Rev ; 4(2): 110-21, 2011 Jun.
Article in English | MEDLINE | ID: mdl-21696345

ABSTRACT

Nicotine, the primary psychoactive compound in tobacco, is responsible for the addictive effects of smoking; however, there is a paucity of information indicating whether the presence of other biological chemicals in tobacco alters nicotine's rewarding effects. It has been suggested that the addictive effects of smoking may be due, in part, to the inhibition of the pair of monoamine oxidase enzymes responsible for a significant fraction of monoamine metabolism, Monoamine Oxidase A and B (MAO-A and MAO-B). This paper reviews the current, limited literature examining the role of MAO inhibition on the rewarding effects of nicotine (e.g., self-administration) in rodents. Overall, studies with rats and mice do suggest that MAO plays a role in nicotine reward. However, results are mixed regarding the MAO subtype responsible for the rewarding effects of nicotine, most likely due to methodological variation across the limited number of studies. Important individual difference factors such as age, sex and genetics are discussed, along with relevant brain and neurotransmitter systems. Future research is needed that builds on the available literature to map out the relationship between MAO inhibition and nicotine reward. These data will enhance our understanding of the neuropharmacological effects of smoking and the value of implementing MAO inhibitors as pharmacotherapies for smoking cessation.


Subject(s)
Monoamine Oxidase Inhibitors/pharmacology , Nicotine/pharmacology , Reward , Animals , Brain/drug effects , Brain/metabolism , Drug Interactions , Neurotransmitter Agents/metabolism , Nicotine/antagonists & inhibitors
9.
J Gerontol B Psychol Sci Soc Sci ; 65(5): 513-25, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20647348

ABSTRACT

Assessment of biomarkers that reflect objective indicators of physiological processes has become increasingly popular in psychological research on stress and aging. The current article reviews biomarkers of the neuroendocrine and immune systems, including issues related to measurement and normative age-related changes. We also discuss how exposure to stressors can provoke changes in these biomarkers and propose that stressful experiences may accelerate age-related declines in these systems. We recommend that future research examining physical health and aging incorporate dynamic and multivariate methods for assessing links between stressors and biomarkers.


Subject(s)
Aging/physiology , Biomarkers/metabolism , Stress, Physiological/physiology , Stress, Psychological/physiopathology , Adrenal Medulla/physiology , Humans , Hypothalamo-Hypophyseal System/physiology , Immune System/physiology , Life Change Events , Sympathetic Nervous System/physiology
10.
Hum Psychopharmacol ; 25(5): 359-67, 2010 Jul.
Article in English | MEDLINE | ID: mdl-20589924

ABSTRACT

OBJECTIVE: We examined the effects of caffeine and a psychological stressor on salivary alpha-amylase (sAA) in healthy young males (age 18-30 years) who consumed caffeine on a daily basis. METHODS: Using a between-subjects, double-blind, placebo-controlled design, 45 participants received either 200 or 400 mg of caffeine (Vivarin) or placebo, rested for 20 min, and then performed 20 min of mental arithmetic. Saliva samples (assayed for sAA and caffeine), blood pressure, and heart rate were taken before (baseline) and 15 min after the math stressor (stress). RESULTS: Baseline sAA activity did not differ among the treatment groups; however, there was a statistically significant time by caffeine group interaction. Changes in sAA activity across the session were dependent on the amount of caffeine consumed. Following the challenge period, sAA activity among the placebo group was the lowest and sAA activity among the 400 mg treatment group was the highest. Separate repeated-measures ANOVAs conducted for each drug treatment group revealed that sAA activity increased in response to stress and caffeine (i.e., 200 and 400 mg groups) but not to stress alone (i.e., placebo group). CONCLUSIONS: Findings provide evidence for acute sAA changes in response to caffeine and stress in habitual caffeine users.


Subject(s)
Caffeine/pharmacology , Saliva/enzymology , Stress, Psychological/enzymology , alpha-Amylases/metabolism , Adolescent , Adult , Analysis of Variance , Blood Pressure/drug effects , Caffeine/administration & dosage , Dose-Response Relationship, Drug , Double-Blind Method , Heart Rate/drug effects , Humans , Male , Young Adult , alpha-Amylases/drug effects
11.
BMC Res Notes ; 3: 204, 2010 Jul 20.
Article in English | MEDLINE | ID: mdl-20646292

ABSTRACT

BACKGROUND: The anabolic steroid, dehydroepiandosterone sulfate (DHEA-S), is secreted from the adrenal cortex. It plays a significant role in the body as a precursor to sex steroids as well as a lesser known role in the hypothalamic pituitary adrenal axis (HPA) response to stress. DHEA-S can be measured reliably in saliva, making saliva collection a valuable tool for health research because it minimizes the need for invasive sampling procedures (e.g., blood draws). Typical saliva collection methods include the use of plain cotton swab collection devices (e.g., Salivette(R)) or passive drool. There has been some speculation that the plain saliva cotton collection device may interfere with determination of DHEA-S by enzyme immunoassay (EIA) bringing this saliva collection method into question. Because of the increasing popularity of salivary biomarker research, we sought to determine whether the cotton swab interferes with DHEA-S determination through EIA techniques. FINDINGS: Fifty-six healthy young adult men and women aged 18-30 years came to the lab in the morning (0800 hrs; 14 men, 14 women) or late afternoon (1600 hrs; 14 men, 14 women) and provided saliva samples via cotton Salivette and passive drool. Passive drool collection was taken first to minimize particle cross contamination from the cotton swab. Samples were assayed for DHEA-S in duplicate using a commercially available kit (DSL, Inc., Webster, TX). DHEA-S levels collected via Salivette and passive drool were positively correlated (r = + 0.83, p < 0.05). Mean DHEA-S levels were not significantly different between collection methods. Salivary DHEA-S levels were significantly higher in males than in females, regardless of saliva collection method (p < 0.05), and morning DHEA-S values were higher than evening levels (p < 0.05). CONCLUSIONS: Results suggest that DHEA-S can be measured accurately using passive drool or cotton Salivette collection methods. Results also suggest that DHEA-S levels change across the day and that future studies need to take this time of day difference into account when measuring DHEA-S.

12.
BMC Res Notes ; 3: 170, 2010 Jun 17.
Article in English | MEDLINE | ID: mdl-20565762

ABSTRACT

BACKGROUND: As a first step in determining whether psychogenic stressors might be incorporated into periadolescent mouse models of stress, we evaluated whether a commonly used psychogenic stressor, exposure to red fox urine, alters serum corticosterone levels in periadolescent C57BL/6J and DBA/2J mice. FINDINGS: In a 1-day experiment, forty-eight 38-day-old C57BL/6J (N = 12 males; N = 12 females) and DBA/2J (N = 12 males; N = 12 females) mice were exposed to 10-min of red fox urine via cotton ball (N = 12 C57BL/6J mice; N = 12 DBA/2J mice) or to a non-saturated cotton ball (N = 12 C57BL/6J mice; N = 12 DBA/2J mice). All mice were sacrificed 15-min after cotton ball exposure and serum was collected for corticosterone assessment. Overall, there was a main effect for strain such that C57BL/6J male and female mice displayed higher corticosterone levels than did male and female DBA/2J mice. There were no main effects for sex or odor exposure. However, there was a significant strain by odor exposure interaction, whereby, within odor-exposed mice, DBA/2J mice displayed lower corticosterone levels (ng/mL) compared to C57BL/6J mice, regardless of sex. Further, among DBA/2J mice, predator odor exposure reduced corticosterone levels compared to no odor exposure. CONCLUSIONS: Findings indicate that mouse strain, but not sex, may play an important role in the efficacy of a predator odor among periadolescent mice.

13.
Physiol Genomics ; 36(3): 158-66, 2009 Feb 02.
Article in English | MEDLINE | ID: mdl-19066325

ABSTRACT

A quantitative trait locus (QTL) approach was used to define the genetic architecture underlying variation in systolic blood pressure (SBP) and heart rate (HR), measured indirectly on seven occasions by the tail cuff procedure. The tests were conducted in 395 F(2) adult mice (197 males, 198 females) derived from a cross of the C57BL/6J (B6) and DBA/2J (D2) strains and in 22 BXD recombinant-inbred (RI) strains. Interval mapping of F(2) data for the first 5 days of measurement nominated one statistically significant and one suggestive QTL for SBP on chromosomes (Chr) 4 and 14, respectively, and two statistically significant QTL for HR on Chr 1 (which was specific to female mice) and Chr 5. New suggestive QTL emerged for SBP on Chr 3 (female-specific) and 8 and for HR on Chr 11 for measurements recorded several weeks after mice had undergone stressful blood sampling procedures. The two statistically significant HR QTL were confirmed by analyses of BXD RI strain means. Male and female F(2) mice did not differ in SBP or HR but RI strain analyses showed pronounced strain-by-sex interactions and a negative genetic correlation between the two measures in both sexes. Evidence for a role for mitochondrial DNA was found for both HR and SBP. QTL for HR and SBP may differ in males and females and may be sensitive to different environmental contexts.


Subject(s)
Blood Pressure/genetics , Heart Rate/genetics , Quantitative Trait Loci/genetics , Animals , Chromosome Mapping/methods , Chromosomes, Mammalian/genetics , Epistasis, Genetic , Female , Genotype , Male , Mice , Mice, Inbred C57BL , Mice, Inbred DBA , Mice, Inbred Strains , Polymorphism, Single Nucleotide , Sex Factors , Stress, Physiological
14.
Toxicol Rev ; 25(1): 55-69, 2006.
Article in English | MEDLINE | ID: mdl-16856769

ABSTRACT

Caffeine is the most widely consumed psychostimulant drug in the world that mostly is consumed in the form of coffee. Whether caffeine and/or coffee consumption contribute to the development of cardiovascular disease (CVD), the single leading cause of death in the US, is unclear.This article examines the effects of caffeine intake, both alone and via coffee consumption, on key blood markers of CVD risk: lipoproteins (cholesterol, triglycerides), fibrinogen (a biomarker of blood clotting) and C-reactive protein (CRP; a biomarker of inflammation). These blood markers and their role in the development of CVD are reviewed first. Studies examining caffeine and coffee effects on each of these blood markers are then presented. Next, biobehavioural moderators of the relationship between caffeine and/or coffee consumption and CVD are discussed, including genetics, sex and tobacco smoking. The literature indicates a strong relationship between boiled, unfiltered coffee consumption and elevated cholesterol levels; however, there is a critical gap in the literature regarding the effects of coffee or caffeine consumption on fibrinogen or CRP, which is an independent predictor of CVD risk. Available studies are limited by small samples sizes, inclusion of only men (or few women) and unrepresented age or ethnic groups. Thiere is a critical need for controlled laboratory and epidemiological studies that include fibrinogen and CRP markers of CVD risk before conclusions can be drawn regarding the health effects of caffeine and/or coffee in a normal, healthy population of men and women.


Subject(s)
C-Reactive Protein/metabolism , Caffeine/adverse effects , Cardiovascular Diseases/chemically induced , Cholesterol/blood , Coffee/adverse effects , Fibrinogen/metabolism , Biomarkers/blood , Cardiovascular Diseases/blood , Cardiovascular Diseases/metabolism , Coffee/chemistry , Humans , Risk
15.
Am J Public Health ; 95(6): 939-45, 2005 Jun.
Article in English | MEDLINE | ID: mdl-15914813

ABSTRACT

Smoking prevalence is shifting from more- to less-developed countries. In higher-income countries, smoking surveillance data, tailored treatments, public health campaigns, and research-based policy implementation have led to a decrease in tobacco use. In low- and middle-income countries, translating research into practice and policy is integral for tobacco control. We describe the landscape of existing resources, both financial and structural, to support global tobacco control research and strengthen research capacity in developing countries. We identify key organizations that support international efforts, provide examples of partnerships between developed and developing countries, and make recommendations for advancing global tobacco research. There is a need for increased commitment from organizations to support global tobacco control research.


Subject(s)
Biomedical Research/economics , Financing, Organized , Global Health , International Agencies/classification , Public Policy , Research Support as Topic/organization & administration , Smoking Prevention , Tobacco Use Disorder/prevention & control , Developing Countries , Health Promotion , Humans , Plants, Toxic , Smoking/adverse effects , Smoking Cessation , Nicotiana/toxicity , Tobacco Use Disorder/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...